Zobrazeno 1 - 10
of 11
pro vyhledávání: '"W C Gruber"'
Autor:
S. Lockhart, W. C. Gruber
Publikováno v:
Vaccine Development ISBN: 9781788018777
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0dd5b572b4aaefa3ad28168da39e7c4c
https://doi.org/10.1039/9781839162572-00050
https://doi.org/10.1039/9781839162572-00050
Autor:
H. Masur, M. Grimley, S. Kottilil, John Fry, J. Hickok, Leo Beigelman, M. Gluck, A. R. Bellamy, S. Edupuganti, C. Richards, M. J. Bonten, Matthew W. McClure, Q. Zhang, P. Winokur, S. Kabbani, M. Bolkenbaas, S. S. Huang, Lisa Harrison, H.-Y. Chiang, P. Sears, C. Scaglioni-Weinlich, Sushmita Chanda, E. J. Anderson, H. Hill, Rob Lambkin-Williams, W. Drews, A. Kohli, John P. DeVincenzo, S. Okubo, A. S. Ross, A. Nelson, D. Jacobsohn, J. Moody, Hosnieh Fathi, E. Perencevich, M. J. Mulligan, J. Duchin, B. Braun, M. Berrey, M. Schweizer, W. C. Gruber, N. Rouphael, S. Flanagan, D. Ince, Lawrence M. Blatt, C. Westland, J. Perlin, C. Webber, S. Klish, K. Wendorf, Z. Sims, T. Brundage, Julian Symons, D. Bernstein, K. Nieforth, E. Meissner, M. O'gorman, L. A. Herwaldt, S. Weissman, M. Zahn, D. E. Grobbee, G. Maron, S. K. Gohil, M. Michaels, Patrick F. Smith, E. Septimus, S. L. Kaplan, D. L. Noah, P. Verma, J. G. Mchutchison, L. Lai, R. Rupp, D. J. Diekema, S. M. Huijts, J.-A. Young, D. A. Scott, M. Dickey, S. D. Patterson, M. Kay, C. Baliga, P. W. Spearman, J. T. Stapleton, G. Chittick, M. Ward, C. S. Team, H. Mommeja-Marin, J. Hafner
Publikováno v:
Open Forum Infectious Diseases. 1:S66-S69
Autor:
S. L. Kaplan, K. J. Center, W. J. Barson, P. Ling-Lin, J. R. Romero, J. S. Bradley, T. Q. Tan, J. A. Hoffman, T. R. Peters, A. Gurtman, D. A. Scott, J. Trammel, W. C. Gruber, K. G. Hulten, E. O. Mason
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 60(9)
Streptococcus pneumoniae is a common cause of otitis media (OM) in children; mastoiditis remains an important complication of OM. Limited data are available on the impact of the 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal otitis.
Autor:
S M, Huijts, W G, Boersma, D E, Grobbee, W C, Gruber, K U, Jansen, J A J W, Kluytmans, B A F, Kuipers, F, Palmen, M W, Pride, C, Webber, M J M, Bonten
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 20(12)
The aim of this study was to quantify the value of clinical predictors available in the emergency department (ED) in predicting Streptococcus pneumoniae as the cause of community-acquired pneumonia (CAP). A prospective, observational, cohort study of
Autor:
E, Hak, D E, Grobbee, E A M, Sanders, T J M, Verheij, M, Bolkenbaas, S M, Huijts, W C, Gruber, S, Tansey, A, McDonough, B, Thoma, S, Patterson, A J, van Alphen, M J M, Bonten
Publikováno v:
The Netherlands journal of medicine. 66(9)
The burden of community-acquired pneumonia (CAP) among the elderly is high and has increased over the last decades. Streptococcus pneumoniae is the most common cause of CAP and in 10% the infection may be fatal. Although the 23-valent polysaccharide
Autor:
Andrés, de Roux, B, Schmöle-Thoma, B, Schmöele-Thoma, G R, Siber, J G, Hackell, A, Kuhnke, N, Ahlers, S A, Baker, A, Razmpour, E A, Emini, P D, Fernsten, W C, Gruber, S, Lockhart, O, Burkhardt, T, Welte, H M, Lode
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 46(7)
Background. High functional antibody responses, establishment of immunologic memory, and unambiguous efficacy in infants suggest that an initial dose of conjugated pneumococcal polysaccharide (PnC) vaccine may be of value in a comprehensive adult imm
Autor:
W J, Rodriguez, W C, Gruber, R C, Welliver, J R, Groothuis, E A, Simoes, H C, Meissner, V G, Hemming, C B, Hall, M L, Lepow, A J, Rosas, C, Robertsen, A A, Kramer
Publikováno v:
Pediatrics. 99(3)
To evaluate the efficacy of high-titer intravenous respiratory syncytial virus immune globulin (RSVIG) in the treatment of children at high risk for severe RSV infection who were hospitalized with proven RSV.Infants and young children younger than 2
Autor:
W C, Gruber, R B, Belshe, J C, King, J J, Treanor, P A, Piedra, P F, Wright, G W, Reed, E, Anderson, F, Newman
Publikováno v:
The Journal of infectious diseases. 173(6)
Live attenuated, cold-adapted (ca) monovalent and bivalent influenza A vaccines were evaluated in seronegative infants (ages 6-18 months) in a double-blind placebo-controlled trial to assess safety and immunogenicity. A total of 182 seronegative subj
Publikováno v:
The Pediatric infectious disease journal. 9(7)
An intravenous immunoglobulin (IVIG) preparation was evaluated prospectively in hospitalized low birth weight infants for the prevention of respiratory virus infection. Premature neonates were evaluated from October 19, 1987, through July 31, 1988. N
Autor:
Pamela S. Diaz, Teresa Murguı́a de Sierra, M Shelton, D W Kimberlin, F D Lakeman, Richard F. Jacobs, Kathleen Gutierrez, Lawrence Corey, John S. Bradley, L B Weiner, R J Whitley, Ann M. Arvin, S J Soong, W C Gruber, Mobeen H. Rathore, C Y Lin, M Kumar, John W Sleasman, D A Powell
Publikováno v:
Pediatric Research. 45:165A-165A
The Safety and Efficacy of High-Dose (HD) Acyclovir (ACV) in Neonatal Herpes Simplex Virus (HSV) Infections